Cholesterol testing for patients with coronary heart disease is often redundant, according to a study published in JAMA Internal Medicine.
The study followed approximately 35,000 coronary heart diseases patients in a Veterans Affairs network over 11 months.
Of the approximately 30,000 heart disease patients with safe LDL levels recorded at a recent visit, one-third were retested unnecessarily for cholesterol levels during an 11-month follow-up period.
Study authors suggest that improving cholesterol medication guidelines for those with coronary heart disease to a dose-based approach rather than a treat-to-target-level approach could greatly reduce the number of redundant tests performed.
More Articles on Quality:
FirstHealth Moore Regional Taken Off Immediate Jeopardy Status
Quality Improvement and Infection Reduction Make Financial Sense, Study Says
Poor Communication Leads to Unsafe Discharges to Skilled Nursing Facilities, Study Finds